Evidence map›Paper›PMID 33434420›Full record

ArticleEnvironmental analysis, health and toxicology2020

Air pollution enhances susceptibility to novel coronavirus (COVID-19) infection - an impact study.

S Maheswari, Rajarajan Pethannan, Shanthi Sabarimurugan

Open access · hybridAbstract read
In one paragraph

Article in Environmental analysis, health and toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Coronavirus disease 2019 and lung cancer: where are we?Exploration of targeted anti-tumor therapy · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S MaheswariDepartment of Microbiology, Centre for Research & PG Studies, Indian Academy Degree College - Autonomous, Bangalore, India.
Rajarajan PethannanDepartment of Microbiology, Centre for Research & PG Studies, Indian Academy Degree College - Autonomous, Bangalore, India.
Shanthi SabarimuruganTheranostics, GenesisCare, WA, Australia.
The University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On concurring to the current evidence, the myriad of vulnerable COVID-19 (Coronavirus Disease 19) transmission is acquiring through human-to-human transmission through droplets, which is depicting devastating pandemic. Urbanization and industrialization are the major contributing factors to the on-going change in global climate, with increased air pollution and poor air quality. As the global climate and air quality deteriorate, air pollutants remain as a fundamental concern to public health. Air pollution has been globally acknowledged as a major influence and exacerbating factor for human morbidity and mortality influenced on various respiratory diseases such as lung cancer, bronchitis, chronic obstructive pulmonary diseases, pneumonia, asthma, and influenza. Patients by long - term exposure to polluted air leads to chronic lung and heart conditions are less able to fight off lung infections and likely to die. Polluted air in developed countries is causing heart and lung damage and is responsible for early deaths in a year. This is also likely the case for COVID-19. The more severe impact by COVID-19 on city dwellers and those exposed to toxic fumes leads to the primary health damage such as respiratory infections than on others. The health damage inflicted on people by long-standing air pollution in cities is likely to increase the death rate by COVID-19. By lowering air pollution levels probability to reduce the spread of most vulnerable viruses by aerosol to fight against any possible future pandemics.

Indexed as

air pollutantsCOVID-19MERSrespiratory diseasesSARS

Identifiers

PMID33434420
PMCPMC7829407
OpenAlexW3095687807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.